Cardinal Health Net Acquisitions/Divestitures 2010-2025 | CAH
Cardinal Health annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- Cardinal Health net acquisitions/divestitures for the quarter ending March 31, 2025 were $-3.853B, a 225.7% increase year-over-year.
- Cardinal Health net acquisitions/divestitures for the twelve months ending March 31, 2025 were $-6.106B, a 415.71% increase year-over-year.
- Cardinal Health annual net acquisitions/divestitures for 2024 were $-1.181B, a 11710% increase from 2023.
- Cardinal Health annual net acquisitions/divestitures for 2023 were $-0.01B, a 101.11% decline from 2022.
- Cardinal Health annual net acquisitions/divestitures for 2022 were $0.901B, a 30133.33% decline from 2021.
Cardinal Health Annual Net Acquisitions/Divestitures
(Millions of US $) |
| 2024 |
$-1,181 |
| 2023 |
$-10 |
| 2022 |
$901 |
| 2021 |
$-3 |
| 2020 |
$N/A |
| 2019 |
$681 |
| 2018 |
$-5,280 |
| 2017 |
$-129 |
| 2016 |
$-3,601 |
| 2015 |
$-503 |
| 2014 |
$-519 |
| 2013 |
$-2,239 |
| 2012 |
$-174 |
| 2011 |
$-2,300 |
| 2010 |
$126 |
| 2009 |
$8 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$36.816B |
$226.827B |
|
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
|
